WYETH LLCCollaboration and License Agreement • August 14th, 2020 • Aptevo Therapeutics Inc. • Pharmaceutical preparations
Contract Type FiledAugust 14th, 2020 Company IndustryThis letter agreement (the "Letter Agreement") constitutes Amendment No. 3 to the Agreement referred to above. Capitalized terms used but not defined herein shall have the meanings set forth in the Agreement. EPDS and Wyeth desire to amend the Agreement with respect to the restrictions on Development and Commercialization of CD20 Antigens and CD20 Products. This Letter Agreement sets forth the agreement of EPDS and Wyeth with respect to such amendment.
WYETH LLC ACTING THROUGH ITS WYETH PHARMACEUTICALS DIVISION COLLEGEVILLE, PENNSYLVANIA 19426 USACollaboration and License Agreement • August 14th, 2020 • Aptevo Therapeutics Inc. • Pharmaceutical preparations
Contract Type FiledAugust 14th, 2020 Company IndustryThis letter agreement (the “Letter Agreement”) constitutes Amendment No. 3 to the Agreement referred to above. Capitalized terms used but not defined herein shall have the meanings set forth in the Agreement. EPDS and Wyeth desire to amend the Agreement with respect to the restrictions on Development and Commercialization of CD20 Antigens and CD20 Products. This Letter Agreement sets forth the agreement of EPDS and Wyeth with respect to such amendment.